Dolby Laboratories (DLB) Tops Q3 EPS by 33c, Offers Guidance

Dolby Laboratories (NYSE: DLB) reported Q3 EPS of $0.68, $0.33 better than the analyst estimate of $0.35. Revenue for the quarter came in at $289.6 million versus the consensus estimate of $295.65 million.

GUIDANCE:

Dolby Laboratories sees Q4 2022 EPS of $0.68-$0.83, versus the consensus of $0.87. Dolby Laboratories sees Q4 2022 revenue of $295-325 billion, versus the consensus of $326.8 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
• Sanara MedTech Inc. (SMTI) Misses Q2 EPS by 2c